Abbott Laboratories (ETR:ABL)

Abbott Laboratories Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	159,969	185,550	189,494	172,877	179,118	212,232
Market Cap Growth	-14.58%	-2.08%	9.61%	-3.48%	-15.60%	38.39%
Enterprise Value	164,642	190,279	196,729	180,897	185,558	220,076
Last Close Price	90.32	105.38	106.81	94.99	96.95	115.44
PE Ratio	28.79	33.39	14.69	33.52	27.72	34.28
PS Ratio	4.24	4.92	4.68	4.76	4.39	5.60
PB Ratio	3.66	4.25	4.10	4.92	5.19	6.70
P/TBV Ratio	8.78	10.19	10.96	31.28	55.76	-
P/FCF Ratio	-	-	30.89	37.77	24.53	27.91
P/OCF Ratio	-	-	22.92	26.32	19.98	22.92
EV/Sales Ratio	4.41	5.04	4.86	4.99	4.54	5.81
EV/EBITDA Ratio	17.02	19.44	19.01	19.11	16.02	19.64
EV/EBIT Ratio	23.30	26.62	27.17	27.69	21.76	27.19
EV/FCF Ratio	-	-	32.07	39.52	25.41	28.94
Debt / Equity Ratio	0.25	0.25	0.32	0.41	0.49	0.53
Debt / EBITDA Ratio	1.13	1.13	1.38	1.48	1.41	1.47
Debt / FCF Ratio	-	-	2.41	3.16	2.30	2.23
Asset Turnover	-	-	0.54	0.54	0.58	0.58
Inventory Turnover	-	-	2.92	2.81	3.37	3.56
Quick Ratio	-	-	1.05	1.00	1.06	1.28
Current Ratio	-	-	1.67	1.64	1.63	1.85
Return on Equity (ROE)	13.16%	13.16%	30.91%	15.11%	19.01%	20.49%
Return on Assets (ROA)	-	-	6.06%	6.11%	7.61%	7.79%
Return on Invested Capital (ROIC)	11.45%	11.58%	14.59%	13.45%	16.96%	17.46%
Return on Capital Employed (ROCE)	-	-	11.10%	12.20%	15.50%	14.80%
Earnings Yield	3.47%	3.00%	6.83%	3.00%	3.62%	2.93%
FCF Yield	-	-	3.24%	2.65%	4.08%	3.58%
Dividend Yield	2.24%	1.94%	2.03%	1.98%	1.85%	1.39%
Payout Ratio	65.46%	-	28.62%	62.13%	47.73%	45.28%
Buyback Yield / Dilution	-0.06%	-0.06%	0.06%	0.85%	1.40%	-0.17%
Total Shareholder Return	2.24%	1.88%	2.08%	2.83%	3.25%	1.22%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.